- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development Unit
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
Julia Meade, MD
- Assistant Professor of Pediatrics
- Director, Pediatric Cancer Predisposition Program
Administrative Assistant: Amanda Hall
Meade is a pediatric oncologist with additional fellowship training in the care of children with brain and spinal cord tumors. Part of her clinical time is spent caring for children in the brain tumor survivorship program at UPMC Children’s Hospital of Pittsburgh. Additionally, Meade sees children and families with cancer predisposition syndromes.
Education & Training
- BA, Wellesley College, 2005
- MD, Texas A&M University Health and Science Center College of Medicine, 2011
- Residency, University of Colorado, 2014
- Fellowship, UT Southwestern Medical Center, 2017
- Fellowship, Northwestern University/Lurie Children's Hospital, 2018
Selected Publications
Venier, R; Maurer, L; Kessler, E; Ranganathan, S.; McGough, R.; Weiss, K.; Malek, M.; Meade, J.; Tersak, J.; Bailey, K. 2019. A germline BARD1 mutation in a patient with Ewing Sarcoma: implications for familial testing and counseling. Jun 3. Pediatr Blood Cancer. PMID: 31157509
Algattas, H; Abou-Al-Shaar, H; Mendelson, M; Arnold, G; Felker, J; Meade, J; Greene, S. 2020. Familial Cerebral Cavernous Malformation Syndrome with concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence? Cancer Genetics, in revision
Bey, E; Meade, J; Silvers, M; Motea, E; Patidar, P; Brekken, R; Deja, S; Merritt, M; Kilgore, J; Liu, Y; Huang, X; Li, L; Yordy, J; Williams, N; Gao, J; Boothman, D. “NQO1 Bioactivatable Drugs Modify Radiation Responses.” (2016) M.S. Anscher, K. Valerie (Eds.), Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Springer International Publishing, Switzerland.
» Academic and Research Interests
- Pediatric Cancer Predisposition Syndromes
- Pediatric Cancer Genetics
- Rare Pediatric Cancers
- Neurofibromatosis